APRIL 21, 2019 Disclaimer In this presentation, all amounts are in - PowerPoint PPT Presentation

Feb 13, 2023 •180 likes •486 views

APRIL 21, 2019 Disclaimer In this presentation, all amounts are in Canadian dollars, unless otherwise indicated. Any graphs, tables or other information in this presentation demonstrating the historical performance of Cardiol or any other entity

APRIL 21, 2019

Download Presentation

Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

Investor Presentation April 2019 DISCLAIMER DISCLAIMER Investor Presentation April 2019 2

Investor Presentation April 2019 DISCLAIMER DISCLAIMER Investor Presentation April 2019 2 2 MANAGEMENT & BOARD George Lucan Cameron Buchanan InsertPic InsertPic Managing Director Non-Executive Director Patrick Clanwilliam

552 views • 26 slides

+ M2 Cobalt April 2, 2019 PRIVATE & CONFIDENTIAL Dis Disclaimer er DISCLAIMER THIS

Jervois Mining + eCobalt Solutions + M2 Cobalt April 2, 2019 PRIVATE & CONFIDENTIAL Dis Disclaimer er DISCLAIMER THIS RELEASE IS NOT FOR DISTRIBUTION TO CANADIAN NEWSIRE SERVICES OR FOR DISSEMINATION IN CANADA This presentation has

169 views • 14 slides

Q1 2019 REVENUE (January 1, 2019 March 31, 2019 ) Conference Call April 24, 2019 DISCLAIMER

Q1 2019 REVENUE (January 1, 2019 March 31, 2019 ) Conference Call April 24, 2019 DISCLAIMER All forward-looking statements reflect Teleperformance managements present expectations of future events and are subject to a number of factors

301 views • 17 slides

1Q19 Results April 29 th , 2019 1Q19 Results 2 April 29 th 2019 Disclaimer This document is

1Q19 Results April 29 th , 2019 1Q19 Results 2 April 29 th 2019 Disclaimer This document is only provided for information purposes and does not constitute, nor should it be interpreted as, an offer to sell or exchange or acquire, or an

465 views • 45 slides

2019 Q1 Results Announcement 25 April 2019 1 Disclaimer The information contained in this

2019 Q1 Results Announcement 25 April 2019 1 Disclaimer The information contained in this presentation is provided for statements reflect the Companys current expectations, beliefs, hopes, informational purpose only, and should not

547 views • 44 slides

Investor Presentation Q4 FY 2019 April 18, 2019 DCB Bank Limited Disclaimer This

Investor Presentation Q4 FY 2019 April 18, 2019 DCB Bank Limited Disclaimer This presentation is strictly confidential and may not be copied, published, distributed, redistributed, disseminated or transmitted, directly or indirectly, in any

926 views • 34 slides

Q1 2019 Production and Operational Update 18 April 2019 Q1 2019 Results 1 Disclaimer This

Q1 2019 Production and Operational Update 18 April 2019 Q1 2019 Results 1 Disclaimer This Document comprises an institutional update presentation (the Presentation) which has been prepared by and is the sole responsibility of Shanta Gold

535 views • 17 slides

April 2019 Disclaimer The content of this document (the Presentation) has not been approved

Results for the period ending 28 February 2019 April 2019 Disclaimer The content of this document (the Presentation) has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000

253 views • 24 slides

presentation 1Q 2019 29 April 2019 1 Disclaimer This document was originally prepared in

Quarterly results presentation 1Q 2019 29 April 2019 1 Disclaimer This document was originally prepared in Spanish. The English version published here is for information purposes only. In the event of any discrepancy between the English and

470 views • 43 slides

+ eCobalt Solutions + M2 Cobalt April / May 2019 2019 PRIVATE & CONFIDENTIAL Dis

Jervois Mining + eCobalt Solutions + M2 Cobalt April / May 2019 2019 PRIVATE & CONFIDENTIAL Dis Disclaimer er DISCLAIMER THIS RELEASE IS NOT FOR DISTRIBUTION TO CANADIAN NEWSIRE SERVICES OR FOR DISSEMINATION IN CANADA This

517 views • 25 slides

CapitaLand Limited 1Q 2019 Financial Results 30 April 2019 1 Disclaimer This presentation may

CapitaLand Limited 1Q 2019 Financial Results 30 April 2019 1 Disclaimer This presentation may contain forward-looking statements that involve risks and uncertainties. Actual future performance, outcomes and results may differ materially from

1.23k views • 77 slides

3M/Q1 2019 FINANCIAL RESULTS SIPCHEM 3M/Q1 2019 EARNINGS CALL Date: Tuesday, April 30, 2019

3M/Q1 2019 FINANCIAL RESULTS SIPCHEM 3M/Q1 2019 EARNINGS CALL Date: Tuesday, April 30, 2019 Time: 03:45 PM (Saudi) 04:45 PM (Dubai) 01:45 PM (London) 08:45 PM (New York) DISCLAIMER Disclaimer and important information in relation to this

584 views • 15 slides

QUARTER 1 2019 RESULTS 22 MAY 2019 8 April 2019 Disclaimer This presentation (the

QUARTER 1 2019 RESULTS 22 MAY 2019 8 April 2019 Disclaimer This presentation (the Presentation) has been prepared by The Ardonagh Group Limited (Ardonagh or the Group) and is its sole responsibility. For the purposes hereof, the

666 views • 24 slides

Opportunity Day 2019 1 April 2019 Prompong Chaikul C O N F I D E N T I A L P R O P R I E T A R

Opportunity Day 2019 1 April 2019 Prompong Chaikul C O N F I D E N T I A L P R O P R I E T A R Y Disclaimer Forward-Looking Statement Disclaimer All information and other statements contained in this presentation, other than statements of

933 views • 34 slides

2019 FY Financial Review April 10 th 2020 1 Disclaimer This presentation has been prepared by

2019 FY Financial Review April 10 th 2020 1 Disclaimer This presentation has been prepared by TeamSystem for information purposes only as part of the conference call to present the results as of and for the twelve months ended Dec 31, 2019 of

314 views • 14 slides

CapitaLand Malaysia Mall Trust 1Q 2019 Financial Results 23 April 2019 Disclaimer These

CapitaLand Malaysia Mall Trust 1Q 2019 Financial Results 23 April 2019 Disclaimer These materials may contain forward-looking statements that involve assumptions, risks and uncertainties. Actual future performance, outcomes and results may

467 views • 33 slides

Newer Diabetes Drugs: Results From The EMPA-REG and LEADER Trials Rajiv Roy, MD Endocrinology

Cardiovascular Outcomes With Newer Diabetes Drugs: Results From The EMPA-REG and LEADER Trials Rajiv Roy, MD Endocrinology Sharp Rees-Stealy Medical Group Background Between 1990 and 2010: Incidence of acute MI dropped by approximately

870 views • 37 slides

Cardiac MRI in integrative cardiovascular physiology research Per Lav Madsen MD DMSc Consultant

Cardiac MRI in integrative cardiovascular physiology research Per Lav Madsen MD DMSc Consultant in Cardiology Associate Research Professor ESC CMR and SCMRI level III Dept. Cardiology, Copenhagen University Hospital, Herlev-Gentofte,

1.55k views • 125 slides

CHF Longitudinal Workgroup Addressing readmissions from SNFs and other PAC settings 3/2/17

CHF Longitudinal Workgroup Addressing readmissions from SNFs and other PAC settings 3/2/17 Readmission Rate from SNF by Hospital (CHF) 16 13.6% 14 12 Readmission Rate (%) 10 8 6 Mean = 6.3% 4 2 0% 0 0 10 20 30 40 50 60 70 80

701 views • 13 slides

in Patients with Cardiac Amyloidosis Treated on a Phase 1b Study of Anti- Amyloid mAb CAEL-101

Improvement in Global Longitudinal Strain (GLS) correlates with NT-proBNP response in Patients with Cardiac Amyloidosis Treated on a Phase 1b Study of Anti- Amyloid mAb CAEL-101 Divaya Bhutani MD, Sofia Shames, MD, Jeff Goldsmith, PhD, Siyang

247 views • 20 slides

The Next Generation of CBD TSX: CRDL TSX: CRDL Disclaimer In this presentation, all amounts are

The Next Generation of CBD TSX: CRDL TSX: CRDL Disclaimer In this presentation, all amounts are in Canadian dollars, unless otherwise indicated. Any graphs, tables or other information in this presentation demonstrating the historical

640 views • 30 slides

Hope or Hype? Diabetes Treatment and CV Disease Ines Fonseca Lead Pharmacist Diabetes and

Hope or Hype? Diabetes Treatment and CV Disease Ines Fonseca Lead Pharmacist Diabetes and Endocrinology Sheffield Teaching Hospitals NHS Foundation Trust Learning Outcomes By the end of this session you will be able to: Understand new CV

792 views • 47 slides

Total and viable airborne particulates during orthopaedic surgical procedures PROFESSOR W.R

Total and viable airborne particulates during orthopaedic surgical procedures PROFESSOR W.R WALSH SURGICAL & ORTHOPAEDIC RESEARCH LABORATORIES UNSW AUSTRALIA Study participants Surgeons SORL Dr Richard Verhuel Newcastle Rema

616 views • 44 slides

Raising Funds for Rehabilitation Reh ehab abil ilitat itation ion Se Services ices

Trenton Country Club June 19, 2017 The Newtown Rotarys 28 th Annual Golf Outing Raising Funds for Rehabilitation Reh ehab abil ilitat itation ion Se Services ices Pickering Manor offers a wide range of rehabilitation services to

209 views • 8 slides